• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World

    EC election ‘open, honest and fair’, says David Lok

    Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

    Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

    APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

    APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

    Fossil fuels still missing from latest COP31 draft

    HK-Chile working-holiday scheme to start next year

    HK to contribute to global bay area cooperation: FS

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Cathay Cargo Launches AI Compliance Tool to Streamline Global Trade Operations

    PCCW Global and Druid Technology Partner on Belt and Road IoT Connectivity

    Alipay Launches Domestic Full-Stack Intelligent Agent Platform in Hangzhou

    HKT Posts 4% Profit Rise Amid Steady Local Recovery and AI-Driven Demand

    Alipay Launches AI-Powered Version ‘Abao’ to Streamline Services

    Xiaohongshu Prepares Confidential Hong Kong IPO Filing

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World

    EC election ‘open, honest and fair’, says David Lok

    Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

    Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

    APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

    APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

    Fossil fuels still missing from latest COP31 draft

    HK-Chile working-holiday scheme to start next year

    HK to contribute to global bay area cooperation: FS

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Cathay Cargo Launches AI Compliance Tool to Streamline Global Trade Operations

    PCCW Global and Druid Technology Partner on Belt and Road IoT Connectivity

    Alipay Launches Domestic Full-Stack Intelligent Agent Platform in Hangzhou

    HKT Posts 4% Profit Rise Amid Steady Local Recovery and AI-Driven Demand

    Alipay Launches AI-Powered Version ‘Abao’ to Streamline Services

    Xiaohongshu Prepares Confidential Hong Kong IPO Filing

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News PR Newswire

BPIPO and DCB Partner with LINK-J for the First Regenerative Medicine Investment Event in Tokyo

PR Newswire by PR Newswire
29 April 2025
in PR Newswire
0
BPIPO and DCB Partner with LINK-J for the First Regenerative Medicine Investment Event in Tokyo
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

TOKYO, April 29, 2025 /PRNewswire/ — The inaugural Taiwan-Japan Investment and Industry Networking Event took place at the Global Life Science Hub in Tokyo. The forum united leading biotech and pharmaceutical companies to explore cross-border investment, technology collaboration, and market growth. Key organizations—including BPIPO, DCB, LINK-J, and FIRM—highlighted partnership in regenerative medicine and drug innovation, aiming to bridge Taiwan’s biotech strengths with Japan’s investment and clinical development capabilities.

Strengthening Taiwan-Japan ties, seven pioneering biotech companies showcase innovation in regenerative medicine and drug development. Top: Dr. Hong-Lin Su, DuoGenic StemCells Chairman (right), signing a non-exclusive licensing agreement with Japan’s A&I Co., Ltd. Bottom: Pictured from left to right are Dr. Shuen-iu Hung, AngenMed Therapeutics CEO; Mr. Tang Shan Wen, GNT Chairman; Dr. Chih-Chuan Su, LumiSTAR Biotechnology Senior Business Development Manager; Ms. Fiona Tsai, BIONET Therapeutics Special Assistant to the General Manager; Dr. Sung Yuan Chen, HeXun Biosciences Vice General Manager; and Dr. Richard Shieh, Ascension Medical Biotechnology Chairman. Image: GeneOnline.
Strengthening Taiwan-Japan ties, seven pioneering biotech companies showcase innovation in regenerative medicine and drug development. Top: Dr. Hong-Lin Su, DuoGenic StemCells Chairman (right), signing a non-exclusive licensing agreement with Japan’s A&I Co., Ltd. Bottom: Pictured from left to right are Dr. Shuen-iu Hung, AngenMed Therapeutics CEO; Mr. Tang Shan Wen, GNT Chairman; Dr. Chih-Chuan Su, LumiSTAR Biotechnology Senior Business Development Manager; Ms. Fiona Tsai, BIONET Therapeutics Special Assistant to the General Manager; Dr. Sung Yuan Chen, HeXun Biosciences Vice General Manager; and Dr. Richard Shieh, Ascension Medical Biotechnology Chairman. Image: GeneOnline.

7 Taiwanese Companies Showcase Regenerative Medicine, Immuno-Oncology, and Precision Healthcare

Mr. Keita Komatsu, Deputy Director of the Bio-Industry Division at Japan’s Ministry of Economy, Trade and Industry (METI), expressed optimism for increased support in regenerative medicine investment programs between Taiwan and Japan. During the event, 6 leading Japanese venture capital firms and 30 pharmaceutical and biotech companies, including DCI Partners and Eight Roads Ventures, offered insights and emerging technologies.

Seven Taiwanese regenerative medicine companies were selected to showcase at the event, including:

DuoGenic StemCells Corporation highlighted its stem cell therapies for degenerative diseases. Chairman Hong-Lin Su noted, “Our 3-in-1 solution—platelet-rich fibrin, PBMCs, and growth factors—combines physical and chemical components to control osteoarthritis.” In a similar vein, Ascension Medical Biotechnology Co., Ltd. emphasized its integrated GMP manufacturing and clinical trial results. “We can induce over 100 types of exosomes, targeting a range of diseases,” Chairman Dr Richard Shieh explained.

For cancer care, AngenMed Therapeutics, Inc. presented its immuno-oncology therapies for solid tumors. CEO Shuen-iu Hung stated, “We enable precise anti-tumor immunity and long-term surveillance. Integrating clinical services and trials in Japan will accelerate our impact.”

Meanwhile, GNT Inc. showcased its nanotech and dermatology. Chairman Shan-Wen Tang said “GNT.Tec6, a needle-free, supersonic device for painless, non-invasive drug delivery also deliver exosomes hair follicle, promoting hair growth.”

Similarly, HeXun Biosciences Co., Ltd. offers full CDMO services from R&D to GMP production using automated systems. Vice GM Sung Yuan Chen said, “Automation boosts consistency and helps clients speed up development and ensure quality.

Furthermore, BIONET Therapeutics Corp. presented its AI-driven approach to cell therapies and exosome development. “AI streamlines data analysis and treatment optimization,” said Special Assistant Fiona Tsai. “We’re ready to take our exosome platform global.”

Finally, LumiSTAR Biotechnology, Inc. featured its iPSC Regenerative Medicine & Drug Screening Platform. Senior BD Manager Chih-Chuan Su remarked, “The tech may be complex, but the goal—faster drug discovery—is simple.”

Collectively, these companies highlight Taiwan’s vibrant biotech ecosystem, advancing global healthcare through regenerative medicine, oncology, diagnostics, and AI innovation.

DuoGenic StemCells and A&I Corporation Enter Licensing Agreement

A key highlight was the signing of a licensing agreement between Taiwan-based DuoGenic StemCells and Japan’s A&I Corporation, facilitated by BPIPO and FIRM. The deal grants A&I rights to DuoGenics’ AI Cells technology, therapeutic approvals, marketing, and sales in Japan, marking a milestone in Taiwan-Japan biotech collaboration.

The event not only opens new opportunities for biotech companies but also advances a robust biotech ecosystem rooted in cross-border collaboration.

Tags: prnewswire
PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

Read More

Delivered Korea Showcases K-Beauty and Lifestyle Brands at Melbourne Hallyu Expo, Strengthening Its Presence in Australia

Delivered Korea Showcases K-Beauty and Lifestyle Brands at Melbourne Hallyu Expo, Strengthening Its Presence in Australia

22 November 2026
From sunrise to sundown: Nutriway™ reimagines daily wellbeing with Begin Blend and Metabolism* plus

From sunrise to sundown: Nutriway™ reimagines daily wellbeing with Begin Blend and Metabolism* plus

22 November 2026
  • Trending
  • Comments
  • Latest
Newgen reports Revenue of ₹357 crores in Q1 FY’27, up 11% Q1 YoY; Profit After Tax at ₹63 crores, up 26% Q1 YoY

Newgen Software and the Asian Institute of Digital Finance Forge Strategic Partnership to Shape the Future of Enterprise AI

10 November 2026

World Winter Sports Expo 2026 Opens, Charting a New Decade for Ice and Snow and Outdoor Industries

17 October 2026

HK five-year plan offers UK long-term prospects: CE

10 November 2026
Patriot Launches AI Matrix SSD and DRAM Series Engineered for Local AI Workloads

Patriot Launches AI Matrix SSD and DRAM Series Engineered for Local AI Workloads

19 November 2026

EC election ‘open, honest and fair’, says David Lok

22 November 2026
Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

22 November 2026
APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

22 November 2026

Fossil fuels still missing from latest COP31 draft

22 November 2026

Recent News

EC election ‘open, honest and fair’, says David Lok

22 November 2026
Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

Chongqing International Talent Exchange Conference Opens, Drawing Nobel Laureates and Global Innovators

22 November 2026
APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

APEC Business Travel Card is Linking Zhongshan with Asia-Pacific

22 November 2026

Fossil fuels still missing from latest COP31 draft

22 November 2026
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com